EMA publishes new GDP non-compliance report for wholesaler in Norway
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The European Database EudraGMDP doesn't only contain GMP, but also GDP reports of non-compliance. The Norwegian Authority has issued a statement of non-compliance with GDP for medicinal products of the company Norges NaturmedisinSentral AS, Terminalen 9, Bachetomta næringspark, Lierstranda industriområde, LIER, NO-3414, Norway.
The company was involved in the distribution of medicinal products requiring cold storage and transportation. These operations were not managed under GDP. As a consequence the WDA (Wholesale Distributor Authorisation) has been partly withdrawn. Cold chain activities are now no longer permitted.
Source: EudraGMDP Database (GDP Non-Compliance Report)
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


